NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 283 filers reported holding NEOGENOMICS INC in Q1 2022. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $963,090 | -24.2% | 78,300 | -1.0% | 0.35% | -23.3% |
| Q2 2023 | $1,271,137 | -4.6% | 79,100 | +3.4% | 0.45% | -11.7% |
| Q1 2023 | $1,331,865 | +89.2% | 76,500 | +0.4% | 0.51% | +75.6% |
| Q4 2022 | $704,088 | +17.0% | 76,200 | +9.0% | 0.29% | +14.6% |
| Q3 2022 | $602,000 | +5.1% | 69,900 | -0.5% | 0.25% | +2.8% |
| Q2 2022 | $573,000 | -27.9% | 70,285 | +7.4% | 0.25% | -11.5% |
| Q1 2022 | $795,000 | -59.1% | 65,445 | +14.9% | 0.28% | -56.1% |
| Q4 2021 | $1,943,000 | +32.8% | 56,945 | +87.8% | 0.64% | +26.4% |
| Q3 2021 | $1,463,000 | +23.0% | 30,330 | +15.2% | 0.50% | +28.0% |
| Q2 2021 | $1,189,000 | +5.7% | 26,330 | +12.9% | 0.39% | -5.1% |
| Q1 2021 | $1,125,000 | -6.2% | 23,330 | +4.7% | 0.41% | -12.5% |
| Q4 2020 | $1,200,000 | +158.1% | 22,280 | +76.8% | 0.47% | +115.0% |
| Q3 2020 | $465,000 | +114.3% | 12,600 | +80.0% | 0.22% | +105.6% |
| Q2 2020 | $217,000 | – | 7,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 2,023,355 | $91,395,000 | 37.83% |
| Blue Water Life Science Advisors, LP | 702,222 | $31,719,000 | 11.94% |
| Burrage Capital Management LLC | 147,921 | $6,682,000 | 6.70% |
| PERKINS CAPITAL MANAGEMENT INC | 158,300 | $7,150,000 | 4.06% |
| First Light Asset Management, LLC | 1,148,945 | $51,898,000 | 3.11% |
| Soleus Capital Management, L.P. | 352,007 | $15,900,000 | 2.44% |
| Ranger Investment Management | 832,286 | $37,594,000 | 1.96% |
| Avidity Partners Management LP | 1,367,000 | $61,747,000 | 1.67% |
| Bullseye Asset Management LLC | 108,672 | $4,909,000 | 1.65% |
| Tygh Capital Management, Inc. | 255,541 | $11,543,000 | 1.57% |